• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation?

Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation?

Details
Files
DOI
10.48350/156858
Publisher DOI
10.1016/j.trim.2021.101419
PubMed ID
34089821
Abstract
The intracellular enzyme heme oxygenase-1 (HO-1) is responsible for the degradation of cell-free (cf) heme. Cfheme, released upon cell damage and cell death from hemoglobin, mitochondria and myoglobin, functions as a powerful damage-associated molecular pattern (DAMP). Indeed, cfheme plays a role in a myriad of diseases characterized by (systemic) inflammation, and its rapid degradation by HO-1 is pivotal to maintain homeostasis. In the past decade, HO-1 has been extensively studied for its potential protective role in different transplantation settings, including allogeneic hematopoietic stem cell transplantation (HSCT), solid organ transplantation and pancreatic islet transplantation. These studies have shown that HO-1 can be induced by a wide range of molecules, and that induction of HO-1 has the potential to significantly reduce the incidence and severity of transplantation-related complications such as graft-versus-host disease (GvHD) and ischemia/reperfusion injury (IRI). As such, further investigation into the use of HO-1-inducing agents in human transplantation settings to facilitate the potential use of these agents in the clinic is warranted. In this review, we summarize the literature of the past 10 years on the role of HO-1 in allogeneic HSCT, solid organ transplantation (focusing on kidney and liver) and pancreatic islet transplantation. Furthermore, we provide a hypothesis about the way that HO-1 is able to provide protection against acute GvHD after allogeneic HSCT. A total of 48 research articles and 17 review articles were included in this review.
Date Issued
2021-10
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Subjects
Allogeneic hematopoietic stem cell transplantation Cell-free heme Heme oxygenase-1 Kidney transplantation Liver transplantation Pancreatic islet transplantation
Language(s)
en
Author(s)
Verheij, Myrddin
Zeerleder, Sacha Sergio  
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor  
Department for BioMedical Research, Forschungsgruppe Hämatologie (Erwachsene)  
Voermans, Carlijn
Additional Credits
Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor  
Department for BioMedical Research, Forschungsgruppe Hämatologie (Erwachsene)  
Journal
Transplant immunology
Publisher
Elsevier
ISSN
0966-3274
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: da6d1d [14.09. 16:14]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify